- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 519/00 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or
Patent holdings for IPC class C07D 519/00
Total number of patents in this class: 9321
10-year publication summary
|
455
|
548
|
545
|
544
|
646
|
712
|
895
|
1013
|
960
|
132
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4795 |
193 |
| Hoffmann-La Roche Inc. | 3602 |
179 |
| Gilead Sciences, Inc. | 2134 |
159 |
| Incyte Corporation | 1037 |
156 |
| Merck Sharp & Dohme LLC | 3751 |
155 |
| F. Hoffmann-La Roche AG | 7893 |
136 |
| Janssen Pharmaceutica N.V. | 3340 |
126 |
| Merck Patent GmbH | 5727 |
123 |
| Genentech, Inc. | 4040 |
114 |
| Boehringer Ingelheim International GmbH | 4595 |
111 |
| Takeda Pharmaceutical Company Limited | 2710 |
104 |
| Pfizer Inc. | 3384 |
98 |
| Amgen Inc. | 4290 |
84 |
| Novartis AG | 10494 |
78 |
| Idemitsu Kosan Co., Ltd. | 4232 |
65 |
| Array BioPharma Inc. | 470 |
64 |
| Samsung Display Co., Ltd. | 37127 |
56 |
| ImmunoGen, Inc. | 393 |
56 |
| Medshine Discovery Inc. | 596 |
56 |
| Bayer AG | 3409 |
52 |
| Other owners | 7156 |